Inventor
MITTERER ARTUR
AT53 patents
⚠️ This page may combine multiple inventors who share the name “MITTERER ARTUR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAXTER AG
10 patentsUS6228613B1May 8, 2001
Stable factor VIII/von Willebrand factor complex
BAXTER AG53 citations96
US6579723B1Jun 17, 2003
Method of recovering highly purified vWF or factor VIII/vWF-complex
BAXTER AG34 citations92
US6465624B1Oct 15, 2002
Purification of von-Willebrand factor by cation exchanger chromatography
BAXTER AG31 citations92
US6103693AAug 15, 2000
Method for isolation of highly pure von willebrand factor
BAXTER AG27 citations92
US6086871AJul 11, 2000
Prothrombin derivatives
BAXTER AG39 citations92
US6953837B2Oct 11, 2005
Factor VIII/vWF complexes and compositions
BAXTER AG12 citations82
US6414125B1Jul 2, 2002
Method of chromatographically purifying or fractionating, respectively, von Willebrand factor from a VWF-containing starting material
BAXTER AG9 citations74
US6010844AJan 4, 2000
Methods of preparing and recovering proteins
BAXTER AG13 citations74
US6924151B2Aug 2, 2005
Stable factor VIII/vWF-complex
BAXTER AG3 citations63
US6831159B1Dec 14, 2004
Method for purifying factor VIII/vWF company by cation-exchange chromatography
BAXTER AG2 citations61
IMMUNO AG
9 patentsUS5869617AFeb 9, 1999
High and low molecular weight fractions of von Willebrand Factor and preparations of same
IMMUNO AG47 citations96
US5854403ADec 29, 1998
Method for isolation of highly pure von Willebrand Factor
IMMUNO AG53 citations96
US5633350AMay 27, 1997
Method for the isolation and purification of vitamin K-dependent proteins
IMMUNO AG24 citations93
US5880265AMar 9, 1999
Method for isolation of highly pure von willebrand factor
IMMUNO AG22 citations92
US5892005AApr 6, 1999
High molecular and low molecular fractions of von willebrand factor
IMMUNO AG14 citations82
US5877152AMar 2, 1999
Method for isolation of highly pure von Willebrand Factor
IMMUNO AG14 citations82
US4831121AMay 16, 1989
Polydisperse native pseudomonas flagellar (H) antigens (FAg) and methods of producing them
IMMUNO AG11 citations66
US5576175ANov 19, 1996
Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
IMMUNO AG2 citations63
US5340575AAug 23, 1994
Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
IMMUNO AG3 citations63
BAXALTA INC
6 patentsUS9758568B2Sep 12, 2017
Oligopeptide-free cell culture media
BAXALTA INC10 citations84
US10723761B2Jul 28, 2020
Protein purification by anion exchange chromatography
BAXALTA INC2 citations73
US9732327B2Aug 15, 2017
Formulation of sugar solutions for continuous ultracentrifugation for virus purification
BAXALTA INC2 citations72
US9982286B2May 29, 2018
Medium for the protein-free and serum-free cultivation of cells
BAXALTA INC0 citations52
US9701710B2Jul 11, 2017
Protein purification by anion exchange chromatography
BAXALTA INC0 citations52
US10378004B2Aug 13, 2019
Protein purification by anion exchange chromatography
BAXALTA INC0 citations41
MITTERER ARTUR
5 patentsUS9315560B2Apr 19, 2016
Purification of VWF for increased removal of non-lipid enveloped viruses
MITTERER ARTUR11 citations82
US8388847B2Mar 5, 2013
Methods of concentrating shear-sensitive biopolymers
MITTERER ARTUR6 citations71
US8399632B2Mar 19, 2013
Method for the purification of recombinant blood coagulation factor IX enriched in sulfated and/or phosphorylated molecules
MITTERER ARTUR2 citations61
US8148502B2Apr 3, 2012
R-ALPHA1 antitrypsin anion exchange chromatography
MITTERER ARTUR2 citations61
US8389261B2Mar 5, 2013
Method of isolation and purification of trypsin from pronase protease and use thereof
MITTERER ARTUR0 citations51
BAXTER INNOVATIONS GMBH
4 patentsUS8021881B2Sep 20, 2011
Medium for the protein-free and serum-free cultivation of cells
BAXTER INNOVATIONS GMBH13 citations92
US7648958B2Jan 19, 2010
Factor VIII/vWF-complex and methods of purifying same
BAXTER INNOVATIONS GMBH2 citations58
US9441203B2Sep 13, 2016
Medium for the protein-free and serum-free cultivation of cells
BAXTER INNOVATIONS GMBH0 citations52
US7498146B2Mar 3, 2009
Stable factor VIII/von willebrand factor complex
BAXTER INNOVATIONS GMBH0 citations52
BAXTER HEALTHCARE SA
4 patentsUS6825027B2Nov 30, 2004
Method of production of purified hepatitis a virus particles and vaccine preparation
BAXTER HEALTHCARE SA7 citations71
US7659380B2Feb 9, 2010
Method of isolation and purification of trypsin from pronase protease and use thereof
BAXTER HEALTHCARE SA0 citations51
US7223595B2May 29, 2007
Use of purified Streptomyces griseus trypsin for production of a biomass of cells and viral propagation
BAXTER HEALTHCARE SA0 citations51
US6830917B2Dec 14, 2004
Method of isolation and purification of trypsin from pronase protease and use thereof
BAXTER HEALTHCARE SA0 citations51
TAKEDA PHARMACEUTICALS CO
3 patentsUS11661593B2May 30, 2023
Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
TAKEDA PHARMACEUTICALS CO1 citations72
US12492390B2Dec 9, 2025
Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
TAKEDA PHARMACEUTICALS CO0 citations62
US11421202B2Aug 23, 2022
Virus filtration of cell culture media
TAKEDA PHARMACEUTICALS CO0 citations62
REITER MANFRED
2 patentsBaxalta GmbH
2 patentsBIO PROD & BIO ENG AG
1 patentHASSLACHER MEINHARD
1 patentMUNDT WOLFGANG
1 patentIMMUNO A G
1 patentPLAIMAUER BARBARA
1 patentShowing the top 50 of 53 patents by PatentIndex Score.